Plain-English translation of NCT05463380 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an international research study that collects medical information and blood samples from adults hospitalized with COVID-19. Researchers are trying to understand how different variants of the virus (like delta and omicron) and different vaccines affect how sick people become and how well treatments work.
Since the start of the pandemic, new COVID-19 variants have emerged around the world, but doctors don't fully understand how these variants affect vaccinated and unvaccinated people differently, or how they respond to treatment. This study aims to fill that gap so hospitals can better manage and treat COVID-19 patients.
You likely qualify if…
You likely don't qualify if…
If you are hospitalized with COVID-19, study staff will collect information about your symptoms, medical history, treatments you receive, and how your illness progresses during your hospital stay. They may also collect a blood sample or other biological material for testing. You will not be given any experimental medication — researchers are simply observing and documenting your care and recovery as part of routine hospital treatment across multiple countries.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
Germany
Italy
Kenya
Lithuania